loading
Schlusskurs vom Vortag:
$31.19
Offen:
$31.23
24-Stunden-Volumen:
585.03K
Relative Volume:
1.48
Marktkapitalisierung:
$1.02B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
-83.00
EPS:
-0.37
Netto-Cashflow:
$274.29M
1W Leistung:
+2.37%
1M Leistung:
-11.50%
6M Leistung:
-10.34%
1J Leistung:
+18.75%
1-Tages-Spanne:
Value
$30.67
$31.70
1-Wochen-Bereich:
Value
$29.80
$31.70
52-Wochen-Spanne:
Value
$25.16
$42.29

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name
Firmenname
Collegium Pharmaceutical Inc
Name
Telefon
781-713-3699
Name
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Name
Mitarbeiter
197
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
COLL's Discussions on Twitter

Vergleichen Sie COLL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
COLL
Collegium Pharmaceutical Inc
30.71 1.02B 566.77M 48.16M 274.29M -0.37
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
176.74 80.59B 9.15B 2.43B 2.31B 4.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 44.17B 14.26B 1.55B 0 0.3327
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.57 42.61B 30.27B 1.93B 3.45B 0.444
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.57 18.77B 16.77B -959.00M 1.37B -2.00
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
13.22 15.73B 15.05B -883.30M 1.89B 1.53

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-30 Hochstufung H.C. Wainwright Neutral → Buy
2024-06-07 Hochstufung Jefferies Hold → Buy
2024-05-10 Herabstufung Needham Buy → Hold
2024-05-10 Herabstufung Piper Sandler Overweight → Neutral
2024-01-04 Herabstufung Jefferies Buy → Hold
2023-08-25 Bestätigt Needham Buy
2023-05-02 Fortgesetzt Jefferies Buy
2022-08-08 Herabstufung H.C. Wainwright Buy → Neutral
2022-02-15 Hochstufung Cantor Fitzgerald Neutral → Overweight
2021-08-06 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-01-11 Bestätigt H.C. Wainwright Buy
2020-07-14 Eingeleitet BWS Financial Sell
2020-05-27 Eingeleitet Guggenheim Neutral
2020-02-19 Fortgesetzt Jefferies Buy
2019-10-30 Bestätigt Needham Buy
2019-05-03 Fortgesetzt H.C. Wainwright Buy
2019-04-12 Fortgesetzt Janney Buy
2019-03-20 Eingeleitet SunTrust Hold
2019-01-16 Bestätigt Needham Buy
2018-03-08 Bestätigt H.C. Wainwright Buy
2018-02-07 Bestätigt Needham Buy
2017-12-05 Bestätigt Needham Buy
2017-09-11 Eingeleitet H.C. Wainwright Buy
2017-05-11 Bestätigt Needham Buy
2016-09-13 Eingeleitet Gabelli & Co Buy
2015-06-01 Eingeleitet Jefferies Buy
2015-06-01 Eingeleitet Needham Buy
2015-06-01 Eingeleitet Piper Jaffray Overweight
Alle ansehen

Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten

pulisher
Nov 27, 2024

Rubric Capital Management LP Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 27, 2024
pulisher
Nov 27, 2024

Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $42.60 - Defense World

Nov 27, 2024
pulisher
Nov 26, 2024

Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion - Seeking Alpha

Nov 26, 2024
pulisher
Nov 26, 2024

Massachusetts Financial Services Co. MA Increases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 26, 2024
pulisher
Nov 24, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 24, 2024
pulisher
Nov 22, 2024

Pacer Advisors Inc. Sells 818,721 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 22, 2024
pulisher
Nov 20, 2024

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Amalgamated Bank Has $372,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

121,446 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Acquired by Empowered Funds LLC - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Victory Capital Management Inc. Purchases 215,874 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 18, 2024
pulisher
Nov 14, 2024

Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality - Simply Wall St

Nov 14, 2024
pulisher
Nov 14, 2024

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Rubric Capital Management LP Adjusts Stake in Collegium Pharmace - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - MSN

Nov 13, 2024
pulisher
Nov 12, 2024

Collegium Pharmaceutical Inc (COLL) Stock Price Down 3.67% on No - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Collegium Pharmaceutical to Present at Major Healthcare Investor Conferences | COLL Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Meritage Portfolio Management Purchases New Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

New York State Teachers Retirement System Lowers Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World

Nov 11, 2024
pulisher
Nov 10, 2024

Principal Financial Group Inc. Has $67.46 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Nov 09, 2024
pulisher
Nov 09, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Collegium appoints new CEO Vikram Karnani By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Collegium Pharmaceutical: Q3 Earnings Snapshot - The Washington Post

Nov 08, 2024
pulisher
Nov 08, 2024

Collegium Pharmaceutical Reports Strong Q3 2024 Results - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Collegium Pharmaceutical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Collegium Pharmaceutical Taps Vikram Karnani as CEO - MarketWatch

Nov 07, 2024
pulisher
Nov 07, 2024

Collegium Pharmaceutical earnings beat by $0.04, revenue topped estimates - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Collegium appoints new CEO Vikram Karnani - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Collegium Reports Record Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Collegium Appoints Vikram Karnani as Chief Executive Officer - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Collegium Pharma Names Growth Expert Karnani as CEO Amid Record Revenue Success | COLL Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

A Preview Of Collegium Pharmaceutical's Earnings - Benzinga

Nov 06, 2024
pulisher
Nov 06, 2024

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings - Yahoo Finance

Nov 06, 2024
pulisher
Nov 04, 2024

Collegium Pharmaceutical is Now Oversold (COLL) - Nasdaq

Nov 04, 2024
pulisher
Nov 03, 2024

Emerald Advisers LLC Acquires 177,129 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.60 Average Target Price from Analysts - Defense World

Nov 02, 2024
pulisher
Oct 31, 2024

(COLL) Trading Report - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 31, 2024

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Collegium Pharmaceutical (COLL) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Allspring Global Investments Holdings LLC Has $3.08 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Assenagon Asset Management S.A. Sells 188,423 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? - MSN

Oct 29, 2024

Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$90.27
price up icon 0.83%
$13.13
price up icon 0.00%
$86.59
price up icon 0.19%
$61.00
price up icon 0.41%
$126.59
price down icon 1.03%
$13.22
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):